These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 26070522)
1. Elevated Serum MicroRNA Let-7c in Moyamoya Disease. Zhao S; Gong Z; Zhang J; Xu X; Liu P; Guan W; Jing L; Peng T; Teng J; Jia Y J Stroke Cerebrovasc Dis; 2015 Aug; 24(8):1709-14. PubMed ID: 26070522 [TBL] [Abstract][Full Text] [Related]
2. Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line. Uchino H; Ito M; Kazumata K; Hama Y; Hamauchi S; Terasaka S; Sasaki H; Houkin K BMC Med Genomics; 2018 Aug; 11(1):72. PubMed ID: 30157848 [TBL] [Abstract][Full Text] [Related]
3. let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma. Peng J; Mo R; Ma J; Fan J World J Surg Oncol; 2015 May; 13():175. PubMed ID: 25951903 [TBL] [Abstract][Full Text] [Related]
4. Genetic Analysis of RNF213 c.14576G>A Variant in Nonatherosclerotic Quasi-Moyamoya Disease. Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Nakatomi H; Shimizu T; Saito N J Stroke Cerebrovasc Dis; 2015 May; 24(5):1075-9. PubMed ID: 25817623 [TBL] [Abstract][Full Text] [Related]
5. Expression of serum let-7c, let-7i, and let-7f microRNA with its target gene, pepsinogen C, in gastric cancer and precancerous disease. Liu WJ; Xu Q; Sun LP; Dong QG; He CY; Yuan Y Tumour Biol; 2015 May; 36(5):3337-43. PubMed ID: 25549793 [TBL] [Abstract][Full Text] [Related]
6. Transient middle cerebral artery occlusion in mice induces neuronal expression of RNF213, a susceptibility gene for moyamoya disease. Sato-Maeda M; Fujimura M; Kanoke A; Morita-Fujimura Y; Niizuma K; Tominaga T Brain Res; 2016 Jan; 1630():50-5. PubMed ID: 26556774 [TBL] [Abstract][Full Text] [Related]
7. Endothelial Cell-Derived Let-7c-Induced TLR7 Activation on Smooth Muscle Cell Mediate Vascular Wall Remodeling in Moyamoya Disease. Ma X; Huang Y; He X; Zhang X; Liu Y; Yang Y; Yue P; Liu Y; Gan C; Shu K; Lei T; Wang S; Zhang H Transl Stroke Res; 2023 Aug; 14(4):608-623. PubMed ID: 36181627 [TBL] [Abstract][Full Text] [Related]
8. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans. Park MG; Shin JH; Lee SW; Park HR; Park KP J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162 [TBL] [Abstract][Full Text] [Related]
9. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Miyatake S; Miyake N; Touho H; Nishimura-Tadaki A; Kondo Y; Okada I; Tsurusaki Y; Doi H; Sakai H; Saitsu H; Shimojima K; Yamamoto T; Higurashi M; Kawahara N; Kawauchi H; Nagasaka K; Okamoto N; Mori T; Koyano S; Kuroiwa Y; Taguri M; Morita S; Matsubara Y; Kure S; Matsumoto N Neurology; 2012 Mar; 78(11):803-10. PubMed ID: 22377813 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA let-7c-5p protects against cerebral ischemia injury via mechanisms involving the inhibition of microglia activation. Ni J; Wang X; Chen S; Liu H; Wang Y; Xu X; Cheng J; Jia J; Zhen X Brain Behav Immun; 2015 Oct; 49():75-85. PubMed ID: 25934573 [TBL] [Abstract][Full Text] [Related]
11. Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: Involvement of intrinsic immune reaction in its pathogenesis. Fujimura M; Fujimura T; Kakizaki A; Sato-Maeda M; Niizuma K; Tomata Y; Aiba S; Tominaga T Brain Res; 2018 Jan; 1679():39-44. PubMed ID: 29174692 [TBL] [Abstract][Full Text] [Related]
12. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea. Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859 [TBL] [Abstract][Full Text] [Related]
13. miR-let-7c-3p targeting on Egr-1 contributes to the committed differentiation of leukemia cells into monocyte/macrophages. Qi F; Wang X; Zhao S; Wang C; Sun R; Wang H; Du P; Wang J; Wang X; Jiang G Oncol Lett; 2022 Aug; 24(2):273. PubMed ID: 35782903 [TBL] [Abstract][Full Text] [Related]
14. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review. Liao X; Deng J; Dai W; Zhang T; Yan J Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161 [TBL] [Abstract][Full Text] [Related]
15. Mutation genotypes of RNF213 gene from moyamoya patients in Taiwan. Lee MJ; Chen YF; Fan PC; Wang KC; Wang K; Wang J; Kuo MF J Neurol Sci; 2015; 353(1-2):161-5. PubMed ID: 25956231 [TBL] [Abstract][Full Text] [Related]
16. Let-7c-5p Is Involved in Chronic Kidney Disease by Targeting TGF- Wang Z; Zhou C; Sun Y; Chen Y; Xue D Biomed Res Int; 2020; 2020():6960941. PubMed ID: 32626757 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. Zhao B; Han H; Chen J; Zhang Z; Li S; Fang F; Zheng Q; Ma Y; Zhang J; Wu N; Yang Y Cancer Lett; 2014 Jan; 342(1):43-51. PubMed ID: 23981581 [TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease. Chen JB; Liu Y; Zhou LX; Sun H; He M; You C J Neurosurg; 2016 May; 124(5):1215-20. PubMed ID: 26406790 [TBL] [Abstract][Full Text] [Related]
19. Association between the rs112735431 polymorphism of the RNF213 gene and moyamoya disease: A case-control study and meta-analysis. Huang Y; Cheng D; Zhang J; Zhao W J Clin Neurosci; 2016 Oct; 32():14-8. PubMed ID: 27515544 [TBL] [Abstract][Full Text] [Related]
20. Serum miRNA signature in Moyamoya disease. Dai D; Lu Q; Huang Q; Yang P; Hong B; Xu Y; Zhao W; Liu J; Li Q PLoS One; 2014; 9(8):e102382. PubMed ID: 25093848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]